United States · Bill · S
S. 3077 (114th)
MEDS Act
Introduced
20 June 2016
Last action
—
Status
Read twice and referred to the Committee on the Judiciary.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Marijuana Effective Drug Studies Act of 2016 or the MEDS Act This bill amends the Controlled Substances Act to: establish, with respect to marijuana research, a new federal registration process that is separate from the process for research involving other schedule I drugs; establish a process for registering persons to manufacture or distribute marijuana for purposes of either research or the commercial production of certain approved drugs containing or derived from marijuana; and modify other requirements related to marijuana research and production.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 20 June 2016
Introduced in Senate (PDF)
Introduced in Senate · EN · 20 June 2016
Introduced in Senate
summary · EN · 20 June 2016
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/senate-bill/3077
- Open data entity: https://api.congress.gov/v3/bill/114/s/3077